Breaking barriers in brain cancer treatment:

Overcoming resistance to conquer the fight.

The Ahmed Laboratory

Therapeutic resistance in cancer refers to the ability of cancer cells to become resistant to treatments that are used to try and kill them or slow down their growth. This can happen in a variety of ways, such as mutations in the cancer cells that make them resistant to the therapy or cancer cells changing their characteristics in response to different signals from their environment.

Therapeutic resistance is a major challenge in cancer treatment, and it can lead to poor outcomes for patients. It is an area of active research in our laboratory, where we work to understand the mechanisms of resistance and develop new therapies to overcome it. By developing new treatments that can overcome therapeutic resistance, we may be able to improve outcomes for cancer patients and increase the effectiveness of cancer treatments.

Headshot of Atique U. Ahmed, PhD

Lab Leadership

Atique U. Ahmed, PhD
Associate Professor of Neurological Surgery

Meet Our Team

Contact Us

We welcome your questions and comments and invite you to connect with us if you'd like to explore job opportunities on our team.

Get in Touch